Advertising of medicinal products should be subject to effective, adequate monitoring. Reference in this regard should be made to the monitoring mechanisms set up by Directive 84/450/EEC.
Recital 48, Directive (EU) 2001/83
Judgment of the Court (Third Chamber) of 5 May 2011. Novo Nordisk AS v Ravimiamet.Decision
Recitals 47, 48 and 52 in the preamble to Directive 2001/83 state as follows: The advertising of medicinal products to persons qualified to prescribe or supply them contributes to the information available to such persons. Nevertheless, …
5 May 2011 · 62009CJ0249
Opinion of Mr Advocate General Ruiz-Jarabo Colomer delivered on 18 November 2008. Criminal proceedings against Frede Damgaard.Decision
As regards the provisions governing information supplied to patients, recital 40 in the preamble to that directive requires that they provide a high degree of consumer protection in order that medicinal products may be used correctly on …
18 Nov 2008 · 62007CC0421
Opinion of Mr Advocate General Jääskinen delivered on 19 October 2010. Novo Nordisk AS v Ravimiamet.Decision
Recitals 47, 48 and 52 of Directive 2001/83 concern the advertising of medicinal products to professionals. They provide as follows: The advertising of medicinal products to persons qualified to prescribe or supply them contributes to the …
19 Oct 2010 · 62009CC0249
- celex=31984L0450